Retaglutide is a innovative GLP-1 receptor agonist currently under research for the management of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://amieqvam236672.getblogs.net/71420196/semaglutide-a-potential-solution-for-obesity